The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Editor

Share

Personal info

View

Links

Table of contents

About

Terms

 

E. Michael Lewiecki

New Mexico Clinical Research & Osteoporosis Center

Albuquerque

NM 87106

USA

[email]@aol.com

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • New Mexico Clinical Research & Osteoporosis Center, Albuquerque, NM 87106, USA. 2003 - 2011
  • University of New Mexico School of Medicine, Albuquerque, New Mexico, USA. 2007

References

  1. Osteoporosis update from the 2010 santa fe bone symposium. Lewiecki, E.M., Bilezikian, J.P., Khosla, S., Marcus, R., McClung, M.R., Miller, P.D., Watts, N.B., Maricic, M. J. Clin. Densitom (2011) [Pubmed]
  2. New targets for intervention in the treatment of postmenopausal osteoporosis. Lewiecki, E.M. Nat. Rev. Rheumatol (2011) [Pubmed]
  3. Management of skeletal health in patients with asymptomatic primary hyperparathyroidism. Lewiecki, E.M. J. Clin. Densitom (2010) [Pubmed]
  4. 2009 Santa Fe Bone symposium. Lewiecki, E.M., Bilezikian, J.P., Laster, A.J., Miller, P.D., Recker, R.R., Russell, R.G., Whyte, M.P. J. Clin. Densitom (2010) [Pubmed]
  5. Treatment of osteoporosis with denosumab. Lewiecki, E.M. Maturitas (2010) [Pubmed]
  6. Bone densitometry and vertebral fracture assessment. Lewiecki, E.M. Curr. Osteoporos. Rep (2010) [Pubmed]
  7. Ibandronate does not increase risk of atrial fibrillation in analysis of pivotal clinical trials. Lewiecki, E.M., Cooper, C., Thompson, E., Hartl, F., Mehta, D., Papapoulos, S.E. Int. J. Clin. Pract. (2010) [Pubmed]
  8. Denosumab--an emerging treatment for postmenopausal osteoporosis. Lewiecki, E.M. Expert. Opin. Biol. Ther (2010) [Pubmed]
  9. Emerging drugs for postmenopausal osteoporosis. Lewiecki, E.M. Expert. Opin. Emerg. Drugs (2009) [Pubmed]
  10. Evidence-based medicine, clinical practice guidelines, and common sense in the management of osteoporosis. Lewiecki, E.M., Binkley, N. Endocr. Pract (2009) [Pubmed]
  11. 2008 Santa Fe Bone Symposium: update on osteoporosis. Lewiecki, E.M., Baim, S., Bilezikian, J.P., Eastell, R., LeBoff, M.S., Miller, P.D. J. Clin. Densitom (2009) [Pubmed]
  12. Current and emerging pharmacologic therapies for the management of postmenopausal osteoporosis. Lewiecki, E.M. J. Womens. Health. (Larchmt) (2009) [Pubmed]
  13. Denosumab for joints and bones. Lewiecki, E.M. Curr. Rheumatol. Rep (2009) [Pubmed]
  14. Denosumab update. Lewiecki, E.M. Curr. Opin. Rheumatol (2009) [Pubmed]
  15. Once-monthly oral ibandronate improves biomechanical determinants of bone strength in women with postmenopausal osteoporosis. Lewiecki, E.M., Keaveny, T.M., Kopperdahl, D.L., Genant, H.K., Engelke, K., Fuerst, T., Kivitz, A., Davies, R.Y., Fitzpatrick, L.A. J. Clin. Endocrinol. Metab. (2009) [Pubmed]
  16. Odanacatib, a cathepsin K inhibitor for the treatment of osteoporosis and other skeletal disorders associated with excessive bone remodeling. Lewiecki, E.M. IDrugs (2009) [Pubmed]
  17. Is denosumab better than alendronate in the treatment of osteoporosis? Lewiecki, E.M. Nat. Clin. Pract. Rheumatol (2009) [Pubmed]
  18. New guidelines for the prevention and treatment of osteoporosis. Lewiecki, E.M., Watts, N.B. South. Med. J. (2009) [Pubmed]
  19. Pharmacologic therapy to reduce fracture risk: comment on the clinical practice guidelines of the ACP. Lewiecki, E.M. Nature Clinical Practice. Rheumatology (2009) [Pubmed]
  20. Denosumab for the treatment of postmenopausal osteoporosis. Lewiecki, E.M. Women's. Health. (london,. England) (2009) [Pubmed]
  21. The official positions of the International Society for Clinical Densitometry: perceptions and commentary. Lewiecki, E.M., Baim, S., Langman, C.B., Bilezikian, J.P. J. Clin. Densitom (2009) [Pubmed]
  22. Managing osteoporosis: challenges and strategies. Lewiecki, E.M. Cleve. Clin. J. Med (2009) [Pubmed]
  23. Tumor-induced osteomalacia: lessons learned. Lewiecki, E.M., Urig, E.J., Williams, R.C. Arthritis Rheum. (2008) [Pubmed]
  24. Assessing response to osteoporosis therapy. Lewiecki, E.M., Watts, N.B. Osteoporos. Int (2008) [Pubmed]
  25. Intravenous zoledronic acid for the treatment of osteoporosis. Lewiecki, E.M. Curr. Osteoporos. Rep (2008) [Pubmed]
  26. Proceedings of the Eighth Annual Santa Fe Bone Symposium, August 3-4, 2007. Lewiecki, E.M., Bilezikian, J.P., Cooper, C., Hochberg, M.C., Luckey, M.M., Maricic, M., Miller, P.D. J. Clin. Densitom (2008) [Pubmed]
  27. Adherence to and gastrointestinal tolerability of monthly oral or quarterly intravenous ibandronate therapy in women with previous intolerance to oral bisphosphonates: a 12-month, open-label, prospective evaluation. Lewiecki, E.M., Babbitt, A.M., Piziak, V.K., Ozturk, Z.E., Bone, H.G. Clin. Ther (2008) [Pubmed]
  28. Prevention and treatment of postmenopausal osteoporosis. Lewiecki, E.M. Obstet. Gynecol. Clin. North Am. (2008) [Pubmed]
  29. Report of the International Society for Clinical Densitometry 2007 Adult Position Development Conference and Official Positions. Lewiecki, E.M., Baim, S., Binkley, N., Bilezikian, J.P., Kendler, D.L., Hans, D.B., Silverman, S. South. Med. J. (2008) [Pubmed]
  30. Osteoporosis care at risk in the United States. Lewiecki, E.M., Baim, S., Siris, E.S. Osteoporos. Int (2008) [Pubmed]
  31. Special report on the 2007 adult and pediatric Position Development Conferences of the International Society for Clinical Densitometry. Lewiecki, E.M., Gordon, C.M., Baim, S., Binkley, N., Bilezikian, J.P., Kendler, D.L., Hans, D.B., Silverman, S., Bishop, N.J., Leonard, M.B., Bianchi, M.L., Kalkwarf, H.J., Langman, C.B., Plotkin, H., Rauch, F., Zemel, B.S. Osteoporos. Int (2008) [Pubmed]
  32. Vertebroplasty and kyphoplasty update. Lewiecki, E.M. Curr. Osteoporos. Rep (2008) [Pubmed]
  33. A clinician's perspective on the use of zoledronic acid in the treatment of postmenopausal osteoporosis. Lewiecki, E.M. J. Clin. Densitom (2008) [Pubmed]
  34. International Society for Clinical Densitometry 2007 Adult and Pediatric Official Positions. Lewiecki, E.M., Gordon, C.M., Baim, S., Leonard, M.B., Bishop, N.J., Bianchi, M.L., Kalkwarf, H.J., Langman, C.B., Plotkin, H., Rauch, F., Zemel, B.S., Binkley, N., Bilezikian, J.P., Kendler, D.L., Hans, D.B., Silverman, S. Bone (2008) [Pubmed]
  35. Common mistakes in the clinical use of bone mineral density testing. Lewiecki, E.M., Lane, N.E. Nature Clinical Practice. Rheumatology (2008) [Pubmed]
  36. Two-year treatment with denosumab (AMG 162) in a randomized phase 2 study of postmenopausal women with low BMD. Lewiecki, E.M., Miller, P.D., McClung, M.R., Cohen, S.B., Bolognese, M.A., Liu, Y., Wang, A., Siddhanti, S., Fitzpatrick, L.A. J. Bone Miner. Res. (2007) [Pubmed]
  37. Long dosing intervals in the treatment of postmenopausal osteoporosis. Lewiecki, E.M. Curr. Med. Res. Opin (2007) [Pubmed]
  38. Bazedoxifene and bazedoxifene combined with conjugated estrogens for the management of postmenopausal osteoporosis. Lewiecki, E.M. Expert. Opin. Investig. Drugs (2007) [Pubmed]
  39. Renal safety of intravenous bisphosphonates in the treatment of osteoporosis. Lewiecki, E.M., Miller, P.D. Expert. Opin. Drug. Saf (2007) [Pubmed]
  40. DXA quality matters. Lewiecki, E.M., Binkley, N., Petak, S.M. J. Clin. Densitom (2006) [Pubmed]
  41. Redefining osteoporosis treatment: Who to treat and how long to treat. Lewiecki, E.M., Silverman, S.L. Arq. Bras. Endocrinol. Metabol (2006) [Pubmed]
  42. Bone density testing in clinical practice. Lewiecki, E.M., Borges, J.L. Arq. Bras. Endocrinol. Metabol (2006) [Pubmed]
  43. Denosumab: a promising drug for the prevention and treatment of osteoporosis. Lewiecki, E.M. Womens. Health. (Lond. Engl) (2006) [Pubmed]
  44. Uses and misuses of quantitative ultrasonography in managing osteoporosis. Lewiecki, E.M., Richmond, B., Miller, P.D. Cleve. Clin. J. Med (2006) [Pubmed]
  45. Clinical review: Clinical applications of vertebral fracture assessment by dual-energy x-ray absorptiometry. Lewiecki, E.M., Laster, A.J. J. Clin. Endocrinol. Metab. (2006) [Pubmed]
  46. Assessment of osteoporosis-website quality. Lewiecki, E.M., Rudolph, L.A., Kiebzak, G.M., Chavez, J.R., Thorpe, B.M. Osteoporos. Int (2006) [Pubmed]
  47. RANK ligand inhibition with denosumab for the management of osteoporosis. Lewiecki, E.M. Expert. Opin. Biol. Ther (2006) [Pubmed]
  48. Proceedings of the santa fe bone symposium 2006. Lewiecki, E.M. Women's. Health. (london,. England) (2006) [Pubmed]
  49. Premenopausal bone health assessment. Lewiecki, E.M. Curr. Rheumatol. Rep (2005) [Pubmed]
  50. Response to "The Perspective of the International Osteoporosis Foundation on the Official Positions of the International Society for Clinical Densitometry," by John A. Kanis et al. Lewiecki, E.M., Miller, P.D., Leib, E.S., Bilezikian, J.P. J. Clin. Densitom (2005) [Pubmed]
  51. Review of guidelines for bone mineral density testing and treatment of osteoporosis. Lewiecki, E.M. Curr. Osteoporos. Rep (2005) [Pubmed]
  52. Clinical applications of bone density testing for osteoporosis. Lewiecki, E.M. Minerva Med. (2005) [Pubmed]
  53. Update on bone density testing. Lewiecki, E.M. Curr. Osteoporos. Rep (2005) [Pubmed]
  54. Is alendronate therapy cost-effective for postmenopausal osteopenia?. Lewiecki, E.M. Nature Clinical Practice. Endocrinology & Metabolism (2005) [Pubmed]
  55. Update on osteoporosis. Lewiecki, E.M. Women's. Health. (london,. England) (2005) [Pubmed]
  56. Management of osteoporosis. Lewiecki, E.M. Clin. Mol. Allergy (2004) [Pubmed]
  57. Low bone mineral density in premenopausal women. Lewiecki, E.M. South. Med. J. (2004) [Pubmed]
  58. Special report on the official positions of the International Society for Clinical Densitometry. Lewiecki, E.M., Kendler, D.L., Kiebzak, G.M., Schmeer, P., Prince, R.L., El-Hajj Fuleihan, G., Hans, D. Osteoporos. Int (2004) [Pubmed]
  59. Official positions of the international society for clinical densitometry. Lewiecki, E.M., Watts, N.B., McClung, M.R., Petak, S.M., Bachrach, L.K., Shepherd, J.A., Downs, R.W. J. Clin. Endocrinol. Metab. (2004) [Pubmed]
  60. Nonresponders to osteoporosis therapy. Lewiecki, E.M. J. Clin. Densitom (2003) [Pubmed]
 
WikiGenes - Universities